Association of veterinary third-generation cephalosporin use with the risk of emergence of extended-spectrum-cephalosporin resistance in Escherichia coli from dairy cattle in Japan

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sato, Toyotaka ^a,d   Okubo, Torahiko ^a   Usui, Masaru ^a   Yokota, Shin Ichi ^b   Izumiyama, Satoshi ^c   Tamura, Yutaka ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Nemuro District Agriculture Mutual Aid Association   (Japan)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BETA LACTAMASE; CEFALEXIN; CEFAZOLIN; CEFTAZIDIME; CEFTIOFUR; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; DEOXYCHOLIC ACID; HYDROGEN SULFIDE; LACTOSE; VETERINARY DRUG; ANTIINFECTIVE AGENT; CEFPODOXIME; CEFTIZOXIME; ESCHERICHIA COLI PROTEIN;

AMPC GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BLACMY 2 GENE; BLACTX M 14 GENE; BLACTX M 2 GENE; COLON FLORA; CONTROLLED STUDY; DAIRY CATTLE; DRUG USE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENE LOCATION; GENE MUTATION; IN VITRO STUDY; JAPAN; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; RECTUM; RISK ASSESSMENT; ANALOGS AND DERIVATIVES; ANIMAL; BOVINAE; CATTLE DISEASES; DISK DIFFUSION; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; MICROBIOLOGY; RISK; VETERINARY;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CATTLE; CATTLE DISEASES; CEFTIZOXIME; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DISK DIFFUSION ANTIMICROBIAL TESTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; JAPAN; RISK;

EID: 84899716553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096101     Document Type: Article

References (34)

1. World Health Organization (WHO): Critically Important Antimicrobials for Human Medicine: Categorization for the Development of Risk Management Strategies to contain Antimicrobial Resistance due to Non-Human Antimicrobial Use Report of the Second WHO Expert Meeting, Copenhagen, 2007, 29-31.
2. Chantziaras I, Boyen F, Callens B, Dewulf J (2014) Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries J Antimicrob Chemother 69: 827-834.
3. Chong Y, Yakushiji H, Ito Y, Kamimura T (2011) Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. European Eur J Clin Microbiol Infect Dis 30: 83-87.
4. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, et al (2009) Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63: 72-79.
5. Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM (2009) World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis 49: 132-141.
6. FAO/WHO/OIE: Report of the Joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials (2007) FAO, Rome, Italy.
7. Bertrand S, Weill FX, Cloeckaert A, Vrints M, Mairiaux E, et al. (2006) Clonal emergence of extended-spectrum b-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 44: 2897-2903. (Pubitemid 44228587)
8. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV (2001) Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 45: 2716-2722. (Pubitemid 32906662)
9. Cavaco LM, Abatih E, Aarestrup FM, Guardabassi L (2008) Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob Agents and Chemother 52: 3612-3616.
10. Jouini A, Vinue L, Ben Slama K, Saenz Y, Klibi N, et al. (2007) Characterization of CTX-M and SHV extended-spectrum beta-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 60: 1137-1141. (Pubitemid 47617766)
11. Kojima A, Ishii Y, Ishihara K, Esaki H, Asai T, et al. (2005) Extended-spectrum-beta-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: Report from the Japanese Veterinary Antimicrobial Resistance Monitoring program. Antimicrob Agents Chemother 49: 3533-3537. (Pubitemid 41060612)
12. Liebana E, Batchelor M, Hopkins KL, Clifton-Hadley FA, Teale CJ, et al. (2006) Longitudinal farm study of extended-spectrum β-lactamase-mediated resistance. J Clin Microbiol 44: 1630-1634. (Pubitemid 43726248)
13. Daniels JB, Call DR, Hancock D, Sischo WM, Baker K, et al. (2009) Role of ceftiofur in selection and dissemination of bla(CMY-2) -mediated cephalosporin resistance in Salmonella enterica and commensal Escherichia coli isolates from cattle. Appl Environ Microbiol 2009, 75: 3648-3655.
14. Donaldson SC, Straley BA, Hegde NV, Sawant AA, DebRoy C, et al. (2006) Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves. Appl Environ Microbiol 72: 3940-3948. (Pubitemid 43894855)
15. Singer RS, Patterson SK, Wallace RL (2008) Effects of therapeutic ceftiofur administration to dairy cattle on Escherichia coli dynamics in the intestinal tract. Appl Environ Microbiol 74: 6956-6962.
16. Nuru S, Osbaldiston GW, Stowe EC, Walker D (1972) Fecal microflora of healthy cattle and pigs. Cornell Vet 62: 242-253.
17. Clermont O, Olier M, Hoede C, Diancourt L, Brisse S, et al. (2011) Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. Infect Genet Evol 11: 654-662.
18. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial disk and dilution antimicrobial susceptibility tests for bacteria isolated from animals. Approved standard, 3rd ed. CLSI document 2008, M31-A3. CLSI, Wayne, PA.
19. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing standards 2011, M100-S21. CLSI, Wayne, PA.
20. Xu L, Ensor V, Gossain S, Nye K, Hawkey P (2005) Rapid and simple detection of bla(CTX-M) genes by multiplex PCR assay. J Med Microbiol 54: 1183-1187. (Pubitemid 41783826)
21. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153-2162. (Pubitemid 34596400)
22. The National Molecular Subtyping Network for Foodborne Disease Surveillance: One-day (24-28 h) standardized laboratory protocol for molecular subtyping of Escherichia coli O157:H7, non-typhoidal Salmonella serotypes, and Shigella sonnei by pulsed field gel electrophoresis (PFGE) (2004) MAF, 1-12.
23. Ma L, Ishii Y, Ishiguro M, Matsuzawa H, Yamaguchi K (1998) Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam. Antimicrob Agents Chemother 42: 1181-1186. (Pubitemid 28227917)
24. Kado CI, Liu ST (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bact 145: 1365-1373. (Pubitemid 11097357)
25. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, et al. (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63: 219-228. (Pubitemid 41597366)
26. Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, et al. (2002) Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209: 161-168. (Pubitemid 34465587)
27. Alexander TW, Inglis GD, Yanke LJ, Topp E, Read RR, et al. (2010) Farm-to-fork characterization of Escherichia coli associated with feedlot cattle with a known history of antimicrobial use. Int J Food Microbiol 137: 40-48.
28. Asai T, Kojima A, Harada K, Ishihara K, Takahashi T, et al. (2005) Correlation between the usage volume of veterinary therapeutic antimicrobials and resistance in Escherichia coli isolated from the feces of food-producing animals in Japan. Japan J Infect Dis 58: 369-372. (Pubitemid 43078736)
29. Bergman M, Nyberg ST, Huovinen P, Paakkari P, Hakanen AJ (2009) Association between antimicrobial consumption and resistance in Escherichia coli. Antimicrob Agents Chemother 53: 912-917.
30. Shiraki Y, Shibata N, Doi Y, Arakawa Y (2004) Escherichia coli producing CTXM-2 beta-lactamase in cattle, Japan. Emerg Infect Dis 10: 69-75. (Pubitemid 38040695)
31. Sugawara M, Komori J, Kawakami M, Izumiya H, Watanabe H, et al. (2011) Molecular and phenotypic characteristics of CMY-2 beta-lactamase-producing Salmonella enterica serovar Typhimurium isolated from cattle in Japan. J Vet Med Sci 73: 345-349.
32. Matsumoto Y, Kitazume H, Yamada M, Ishiguro Y, Muto T, et al. (2007) CTX-M-14 type beta-lactamase producing Salmonella enterica serovar Enteritidis isolated from imported chicken meat. Japan J Infectious Dis 60: 236-238. (Pubitemid 47365052)
33. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 48: 1-14.
34. Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, et al. (2010) Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors. Int J Antimicrob Agents 35: 444-450.